Your browser doesn't support javascript.
loading
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.
Ceribelli, Michele; Kelly, Priscilla N; Shaffer, Arthur L; Wright, George W; Xiao, Wenming; Yang, Yibin; Mathews Griner, Lesley A; Guha, Rajarshi; Shinn, Paul; Keller, Jonathan M; Liu, Dongbo; Patel, Paresma R; Ferrer, Marc; Joshi, Shivangi; Nerle, Sujata; Sandy, Peter; Normant, Emmanuel; Thomas, Craig J; Staudt, Louis M.
Afiliação
  • Ceribelli M; Lymphoid Malignancies Branch and.
  • Kelly PN; Lymphoid Malignancies Branch and.
  • Shaffer AL; Lymphoid Malignancies Branch and.
  • Wright GW; Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
  • Xiao W; Lymphoid Malignancies Branch and.
  • Yang Y; Lymphoid Malignancies Branch and.
  • Mathews Griner LA; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Guha R; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Shinn P; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Keller JM; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Liu D; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Patel PR; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Joshi S; Constellation Pharmaceuticals, Inc., Cambridge, MA 02142.
  • Nerle S; Constellation Pharmaceuticals, Inc., Cambridge, MA 02142.
  • Sandy P; Constellation Pharmaceuticals, Inc., Cambridge, MA 02142.
  • Normant E; Constellation Pharmaceuticals, Inc., Cambridge, MA 02142.
  • Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892; and.
  • Staudt LM; Lymphoid Malignancies Branch and lstaudt@mail.nih.gov.
Proc Natl Acad Sci U S A ; 111(31): 11365-70, 2014 Aug 05.
Article em En | MEDLINE | ID: mdl-25049379
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Linfoma Difuso de Grandes Células B / Proteínas Serina-Treonina Quinases / Inibidores de Proteínas Quinases / Quinase I-kappa B Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Linfoma Difuso de Grandes Células B / Proteínas Serina-Treonina Quinases / Inibidores de Proteínas Quinases / Quinase I-kappa B Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article